Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study

Fig. 3

Cumulative renal survival according to rapid or slow progression evaluated by one marker in subjects with rapid progression stratified by the other marker. In the cystatin C-based rapid progression group (n = 463), the creatinine-based rapid progression group showed a higher incidence of end-stage renal disease (ESRD) than the creatinine-based slow progression group (p < 0.0001) (a). In the creatinine-based rapid progression group (n = 503), the cystatin C-based rapid progression group showed a higher incidence of ESRD than the cystatin C-based slow progression group (p < 0.0001) (b)

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us